摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-amino-1-hexanol | 82082-21-1

中文名称
——
中文别名
——
英文名称
5-amino-1-hexanol
英文别名
5-aminohexan-1-ol
5-amino-1-hexanol化学式
CAS
82082-21-1
化学式
C6H15NO
mdl
——
分子量
117.191
InChiKey
OLHAHFKZASPGCF-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.1
  • 重原子数:
    8
  • 可旋转键数:
    4
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    46.2
  • 氢给体数:
    2
  • 氢受体数:
    2

反应信息

  • 作为反应物:
    描述:
    5-amino-1-hexanol氯化亚砜 、 sodium iodide 作用下, 以 丙酮 、 xylene 、 为溶剂, 反应 36.0h, 生成 1-iodo-5-phthalimidohexane
    参考文献:
    名称:
    Antimalarials. 13. 5-Alkoxy analogs of 4-methylprimaquine
    摘要:
    A series of nuclear and side-chain analogues of 4-methylprimaquine incorporating an alkoxy group in the 5-position of the quinoline nucleus has been prepared. The compounds were tested for suppressive antimalarial activity against Plasmodium berghei in mice and for radical curative antimalarial activity against Plasmodium cynomolgi in the rhesus monkey. Although the toxicity problems characteristic of the 8-aminoquinolines were not overcome, several of the compounds, surprisingly, were highly effective as both blood and tissue schizonticidal agents.
    DOI:
    10.1021/jm00350a016
  • 作为产物:
    描述:
    1-己烯-5-胺盐酸sodium hydroxide 、 9-borabicyclo[3.3.1]nonane dimer 、 双氧水三乙胺 作用下, 以 甲醇 为溶剂, 反应 36.5h, 生成 5-amino-1-hexanol
    参考文献:
    名称:
    硼氢化反应中伯胺和仲胺的正丁氧基羰基保护:氨基醇的合成
    摘要:
    摘要 描述了 BOC 基团在氨基烯烃硼氢化反应中作为保护基团的用途。通过硼氢化-氧化序列分离出的氨基醇产率非常好。
    DOI:
    10.1080/00397919508015894
点击查看最新优质反应信息

文献信息

  • Inhibitors of histone deacetylase
    申请人:——
    公开号:US20020177594A1
    公开(公告)日:2002-11-28
    Compounds having the formula 1 or therapeutically acceptable salts thereof, are histone deacetylase (HDAC) inhibitors. Preparation of the compounds, compositions containing the compounds, and treatment of diseases using the compounds are disclosed.
    具有以下化学式的化合物或其治疗上可接受的盐是组蛋白去乙酰化酶(HDAC抑制剂。本文揭示了该化合物的制备、含有该化合物的组合物以及使用该化合物治疗疾病的方法。
  • [EN] FUSED RING PYRIMIDONE DERIVATIVES FOR USE IN THE TREATMENT OF HBV INFECTION OR OF HBV-INDUCED DISEASES<br/>[FR] DÉRIVÉS DE PYRIMIDONE À CYCLES FUSIONNÉS DESTINÉS À ÊTRE UTILISÉS DANS LE TRAITEMENT D'UNE INFECTION PAR LE VIRUS DE L'HÉPATITE B OU DE MALADIES INDUITES PAR LE VIRUS DE L'HÉPATITE B
    申请人:JANSSEN SCIENCES IRELAND UNLIMITED CO
    公开号:WO2020182990A1
    公开(公告)日:2020-09-17
    The present application relates to compounds according to Formula (I), pharmaceutical compositions comprising at least one of said compounds, their use as a medicament, and their use in treating chronic hepatitis B virus (HBV) infection. The disclosure further pertains to methods for preparing compounds according to Formula (I).
    本申请涉及按照式(I)的化合物,包括至少一种所述化合物的药物组合物,其作为药物的用途,以及其在治疗慢性乙型肝炎病毒(HBV)感染中的用途。该公开还涉及按照式(I)制备化合物的方法。
  • [EN] SUBSTITUTED ADIPIC ACID AMIDES AND USES THEREOF<br/>[FR] AMIDES DE L'ACIDE ADIPIQUE SUBSTITUÉS ET LEURS UTILISATIONS
    申请人:BRISTOL MYERS SQUIBB CO
    公开号:WO2012125622A1
    公开(公告)日:2012-09-20
    The present invention provides compounds of Formula (I), or a pharmaceutically acceptable salt thereof, wherein A is a five to eight membered monocyclic or a nine to twelve membered bicyclic heterocyclic ring, as further defined herein; Y is S, CH2, or CH; Z is CH or N; R7 and R9 are hydrogen or (C1-C6)alkyl; R2 is (C1 C6)alkoxy, OH, CN, (C1-C6)alkyl, halogen, or CF3; r and s are 0, 1, or 2; and R1 and R3 are as further defined herein. These compounds are agonists, partial agonists and/or modulators of the NPY4 receptor and may be used for the treatment and prophylaxis of obesity, food intake, and other diseases and conditions modulated by the NPY4 receptor.
    本发明提供了式(I)的化合物或其药学上可接受的盐,其中A是一个五至八元的单环或一个九至十二元的双环杂环环,如本文所进一步定义;Y是S、CH2或CH;Z是CH或N;R7和R9是氢或(C1-C6)烷基;R2是(C1-C6)烷氧基、羟基、基、(C1-C6)烷基、卤素或三甲基;r和s为0、1或2;R1和R3如本文所进一步定义。这些化合物是NPY4受体的激动剂、部分激动剂和/或调节剂,可用于治疗和预防肥胖、食物摄入和其他由NPY4受体调节的疾病和症状。
  • [EN] PROCESS FOR PRODUCING ISOCYANATES<br/>[FR] PROCÉDÉ DE PRODUCTION D'ISOCYANATES
    申请人:3M INNOVATIVE PROPERTIES CO
    公开号:WO2011130032A1
    公开(公告)日:2011-10-20
    The invention relates a process for producing isocyanates comprising the steps of a) providing an azolide and optionally a solvent, and b) adding an acid at a temperature below about 40C. The invention also relates to the isocyanate obtainable by such a process.
    该发明涉及一种生产异氰酸酯的方法,包括以下步骤:a)提供一种氮杂环酯和可选的溶剂,b)在约40摄氏度以下的温度下加入酸。该发明还涉及通过这种方法获得的异氰酸酯
  • Process for producing isocyanates
    申请人:3M Innovative Properties Company
    公开号:EP2377847A1
    公开(公告)日:2011-10-19
    The invention relates a process for producing isocyanates comprising the steps of a) providing an azolide and optionally a solvent, and b) adding an acid at a temperature below about 40°C. The invention also relates to the isocyanate obtainable by such a process.
    该发明涉及一种生产异氰酸酯的方法,包括以下步骤:a)提供一种环氧酮酯和可选的溶剂,b)在低于约40°C的温度下加入酸。该发明还涉及通过这种方法获得的异氰酸酯
查看更多